Team Introduction - BBI LIFE SCIENCES CORPORATION

English

SUB WEB

Team Introduction

EXECUTIVE DIRECTORS
NON-EXECUTIVE DIRECTOR
INDEPENDENT NON-EXECUTIVEDIRECTORS
SENIOR MANAGEMENT

Mr. WANG Qisong

Chairman and executive Director
- Mr. WANG Qisong , aged 76, is the founder of our Group. He was appointed as a Director and the chairman of the Board on 16 January 2014 and became our executive Director on 10 October 2014, and is primarily responsible for our Group’s development, positioning and strategy planning. He was one of the founders of Shanghai Sangon Biological Engineering Technology & Services Co, Ltd.* (“SSBETS”) in 2001, was a director of Bio Basic USA Inc. (“BBI US”) from 2009 to 2010 and is currently chairman and director of Sangon Biotech and an executive director of Shanghai Qisong Investment Consulting CompanyLimited* (“BBI China”).
- Mr. Wang has nearly 50 years of experience in the biotechnology industry. Prior to joining our Group, from August 1965 to May 1985, he worked as an assistant researcher in the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, China Academy of Sciences and from March 1980 to March 1983, Mr. Wang Qisong was seconded to the University of Toronto in Canada as a visiting scholar. From June 1985 to October 1991, he was an associate professor in the Institute of Genetics, School of Life Sciences, Fudan University. From June 1987 to December 1989, he was an expert member in the Biotechnology Group of the State High-Tech Development Plan (863 Programme)* . From March 1991 to August 1991, he was a consultant in the United Nations Industrial Development Organization . He is currently a supervisor of Wuhan Wenwang Cultural Education and Communication Limited* .
- Mr. Wang graduated from Wuhan University in Hubei Province, PRC with a Bachelor of Science in Organic Chemistry in July 1965.
- Mr. Wang is the father of Ms. Wang Luojia and Ms. Wang Jin.
Ms. WANG Luojia

Chief executive officer and executive Director
- Ms. WANG Luojia, aged 48, was appointed as an executive Director and the chief executive officer of our Company on 26 September 2014 and 16 January 2014 respectively and is primarily responsible for our Group’s strategies and overall operation management. Ms. Wang is currently a director of Bio Basic Canada Inc. (“Bio Basic (Canada)”), Sangon Biotech, BBI Asia Limited (“BBI Asia”) and BBI International Limited (“BBI International”).
- Ms. Wang graduated from the University of Calgary in Alberta, Canada with a Bachelor of Science in Chemistry in June 1995. In April 2006, she returned to China and worked as a general manager at SSBETS. Subsequently, shebecame general manager of Sangon Biotech in October 2009
- Ms. Wang is the daughter of Mr. Wang Qisong and sister of Ms. Wang Jin.
Ms. WANG Luojia

President and executive Director
- Ms. WANG Jin, aged 46, was appointed as an executive Director and the president of our Company on 26 September 2014 and 16 January 2014 respectively and is primarily responsible for our Group’s strategies and operational management, overseas sales and development, and overall operations of Bio Basic (Canada) and Bio Basic, Inc. (“Bio Basic (US)”). Ms. Wang Jin is currently a director of Bio Basic (Canada), Bio Basic (US), Sangon Biotech, BBI Asia and BBI International.
- Ms. Wang is the daughter of Mr. Wang Qisong and sister of Ms. WANG Luojia.

Mr. XIA Lijun

Independent non-executive Director
- Mr. XIA Lijun , aged 41, was appointed as an independent non-executive Director on 16 January 2014.Mr. Xia was an independent director of Sangon Biotech from 2012 to 2013. From June 2008 to March 2011, hewas a professor in the School of Accountancy in the Shanghai University of Finance and Economics in the PRC. Since March 2011, he has been a professor and head of department in the Department of Accounting,Antai College of Economics and Management, Shanghai Jiao Tong University in the PRC.
- Mr. Xia obtained his Doctor of Philosophy in Management (Accounting) from the Shanghai University of Finance and Economics in the PRC in March 2006.
- Mr. Xia has been an independent director of Shanghai Guangdian Electric Group Co. Ltd. (stock code: 601616), acompany listed on the Shanghai stock exchange, since April 2014.
Mr. HO Kenneth Kai Chung

Independent non-executive Director
- Mr. HO Kenneth Kai Chung, aged 52, was appointed as an independent non-executive Director on 10 October 2014.
- Mr. Ho has served successively as head of China research, China strategist and equity sales in top international investment banks, including Credit Lyonnais, Jardine Fleming, JP Morgan and HSBC, from 1999 to 2013. From 2008 to 2010, he set up Beijing research office for HSBC, established and acted as leader of the local research team as well as the chief representative for the research office. From 2011 till January 2013, Mr. Ho worked as a Hong Kong China equity sales director for HSBC. From January 2014 to March 2015, Mr. Ho served as a director for Munsun Asset Management (Asia) Limited.
- Mr. Ho obtained his Bachelor of Economics from The University of Sydney in May 1988 and Master of Commence in Finance from The University of New South Wales in April 1991. Mr. Ho was awarded a Chartered Financial Analyst in January 1999.
- Mr. Ho has been an independent non-executive director of TK Group (Holdings) Limited (stock code: 2283), a company listed on the Stock Exchange, since 27 November 2013. Mr. Ho had been an independent non-executive director of Evershine Group Holdings Limited (stock code: 8022) (formerly known as TLT Lottotainment Group Limited), a company listed on the Growth Enterprise Market of the Stock Exchange, since 22 November 2013 to 1 April 2014. Mr. Ho has served as a director for Fifth Element Resources Ltd. (stock code: FTH), a company listed on the Australian Securities Exchange since 11 February 2015.
- From August 2015, Mr Ho became the Chief Financial Officer and joint company secretary for Greentown Service Group Co. Ltd. (Stock Code: 2869), a Company listed on the Stock Exchange since July 2016.
- Mr. Ho has been an independent non-executive director of Tsaker Chemical Group Limited (stock code: 01986) a company listed on the Stock Exchange, since 5 March 2015.
Mr. LIU Jianjun

Independent non-executive Director
- Mr. LIU Jianjun, aged 49, was appointed as an independent non-executive Director on 10 October 2014. Mr. Liu was in the legal department of China Ocean Shipping (Group) Company container lines from July 1993 to March 1999, a partner at Zhong Sheng Law Firm, Beijing from April 2001 to October 2006, a senior associate in ZhongLun Law Firm, Beijing from November 2006 to May 2007, and a partner at Zhonglun W&D Law Firm, Beijing from June 2007 to around 2012. Mr. Liu started practicing as a lawyer in the PRC in August 2001.
- Mr. Liu obtained a master degree in law from Peking University, the PRC, in July 1998, and a law degree from Washington University in St. Louis, the U.S., in May 2004.

Mr. LI Ruifeng

Vice president
- Mr. LI Ruifeng, aged 41, was appointed as a vice president of our Company on 16 January 2014. Mr.Li joined SSBETS in 2001 and has been a director and deputy general manager of Sangon Biotech since May 2008and October 2009 respectively. He finished his undergraduate course in microbiology at Inner Mongolia Universityin the PRC in July 2001.
Mr. LI Wei

Vice president
- Mr. LI Wei , aged 34, was appointed as a vice president of our Company on 16 January 2014. He joinedSSBETS and Sangon Biotech in August 2009 and October 2009 respectively, and since May 2010 has been a deputygeneral manager of Sangon Biotech. Mr. Li was a research assistant at the Plant Biotechnology Research Centre of Shanghai Jiao Tong University from September 2008 to August 2009. Mr. Liobtained his Doctor of Philosophy in Genetics from Fudan University in Shanghai in January 2012.
Mr. YAN Hua

Vice president
- Mr. YAN Hua, aged 51, was appointed as a vice president of our Company on 16 January 2014. He joined our Group in June 2011 as technical director and since June 2012 has been a deputy general manager of Sangon Biotech. From February 2008 to May 2011, Mr. Yan was a deputy general manager of Neweast (Wuhan) Biosciences Limited. Mr. Yan obtained his Doctor of Philosophy in Immunology from Wuhan Institute of Biological Products in Hubei Province, PRC in 2012.
Mr. GU Xiaolei

Chief financial office
- Mr. GU Xiaolei (顧曉磊), aged 40, was appointed as the chief financial officer of our Company on 11 September 2015. Mr. Gu has over 15 years of financial management experience in bio-medical industry in the PRC. Mr. Gu holds a Bachelor degree in Economics from Shanghai University of Financial and Economics
Mr. WANG Zhi

Senior manager
- Mr. WANG Zhi, aged 40, was appointed as a senior manager of our Company on 16 January 2014. Mr. Wang joined SSBETS in June 2001 and our Group in October 2009, and has been the DNA synthesis department director of Sangon Biotech since October 2012. Mr. Wang obtained his Master of Business Administration from Donghua University in Shanghai in May 2011.
Mr. ZHOU Mi

Senior manager
- Mr. ZHOU Mi, aged 34, was appointed as a department director of our Company on 16 January 2014. Hejoined BBI Canada in November 2007, and has been a department director of Bio Basic (Canada) and Bio Basic (US) since January 2011 and April 2011, respectively. Mr. Zhou obtained his Bachelor of Science in Biochemistry from Carleton University in Ottawa, Canada in June 2007.

English

SUB WEB

BBI

NEWS

PRODUCTS & SERVICES

INVESTOR RELATIONS

Contact US